Stocks and Investing Stocks and Investing
Tue, July 14, 2020
Mon, July 13, 2020

Serge Belanger Maintained (TRVI) at Strong Buy with Decreased Target to $12 on, Jul 13th, 2020


Published on 2024-10-27 09:30:47 - WOPRAI, Serge Belanger
  Print publication without navigation


Serge Belanger of Needham, Maintained "Trevi Therapeutics, Inc." (TRVI) at Strong Buy with Decreased Target from $18 to $12 on, Jul 13th, 2020.

Serge, nor any peers, have made any analyst calls on TRVI in the last 4 months.

Warning: Undefined array key "user_peer_history" in /tmp/a6c06072cf4de09d3b84c924bfa9ab126ebc2b66_0.file.analysis.tpl.php on line 30

Contributing Sources